Baxter International (BAX) - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0718131099
Baxter International Inc. is a global company that develops and supplies a wide range of healthcare products across the world. The company operates through four key segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care.
Some of the products offered by Baxter include sterile intravenous solutions, infusion systems, parenteral nutrition therapies, generic injectable pharmaceuticals, surgical hemostat products, advanced surgical equipment, patient monitoring technologies, respiratory health devices, and more. The company also provides various services like administrative sets, drug compounding, chronic and acute dialysis therapies, including peritoneal and hemodialysis, and other organ support therapies.
Baxter's products are used in a variety of healthcare settings such as hospitals, dialysis centers, nursing homes, rehabilitation centers, and doctors' offices. Additionally, patients can use Baxter's products at home under physician supervision. The company operates in approximately 100 countries and distributes its products through direct sales, independent distributors, drug wholesalers, and specialty pharmacies.
Established in 1931 and headquartered in Deerfield, Illinois, Baxter International Inc. collaborates with various partners to develop innovative healthcare solutions. It has agreements with companies like Celerity Pharmaceutical, LLC and Miromatrix Medical Inc., aiming to enhance patient care in acute care settings.
For more information about Baxter International Inc., visit their website at https://www.baxter.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
BAX Stock Overview
Market Cap in USD | 21,713m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 1981-10-27 |
BAX Stock Ratings
Growth 5y | -3.84 |
Fundamental | -8.60 |
Dividend | 7.11 |
Rel. Performance vs Sector | -1.28 |
Analysts | 3.59/5 |
Fair Price Momentum | 43.38 USD |
Fair Price DCF | 56.77 USD |
BAX Dividends
Yield 12m | 2.83% |
Yield on Cost 5y | 1.66% |
Dividends CAGR 5y | 6.42% |
Payout Consistency | 94.3% |
BAX Growth Ratios
Growth 12m | -7.06% |
Growth Correlation 12m | -14% |
Growth Correlation 3m | 36% |
CAGR 5y | -10.08% |
Sharpe Ratio 12m | -0.45 |
Alpha vs SP500 12m | -22.87 |
Beta vs SP500 5y weekly | 0.50 |
ValueRay RSI | 42.85 |
Volatility GJR Garch 1y | 23.35% |
Price / SMA 50 | -1.58% |
Price / SMA 200 | 4.78% |
Current Volume | 2646.3k |
Average Volume 20d | 3217.3k |
External Links for BAX Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 24, 2024, the stock is trading at USD 41.02 with a total of 2,646,343 shares traded.
Over the past week, the price has changed by +3.66%, over one month by -2.19%, over three months by +7.52% and over the past year by -6.98%.
According to ValueRays Forecast Model, BAX Baxter International will be worth about 46.9 in April 2025. The stock is currently trading at 41.02. This means that the stock has a potential upside of +14.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 45 | 9.70 |
Analysts Target Price | 47.1 | 14.8 |
ValueRay Target Price | 46.9 | 14.2 |